Kura Oncology, Inc.
Methods of treating cancer with farnesyltransferase inhibitors

Last updated:

Abstract:

The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating cancer, for example, peripheral T-cell lymphoma ("PTCL"), with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on gene expression characteristics.

Status:
Grant
Type:

Utility

Filling date:

14 Aug 2019

Issue date:

20 Apr 2021